-
SIX MONTH OUTCOMES AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY PERSISTENCE AMONG COMMERCIALLY INSURED ADULTS WITHOUT DIABETES IN AN OBESITY CARE MANAGEMENT PROGRAM
Feb 25, 2026, 14:43 PM -
APPLICATION OF CAUSAL FOREST TO IDENTIFY IMPORTANT FEATURES TO EVALUATE HETEROGENEOUS TREATMENT EFFECTS OF DISEASE-MODIFYING THERAPIES IN MULTIPLE SCLEROSIS
Feb 25, 2026, 14:43 PM -
OPERATING ROOM EFFICIENCY AND COST IMPLICATIONS OF THULIUM FIBER LASER VERSUS HOLMIUM:YAG LASER FOR PROSTATE ENUCLEATION: A TARGETED REVIEW, ANALYSIS, AND MODEL
Feb 25, 2026, 14:43 PM -
DISCORDANCE IN MARKET SHARE PARAMETERS IN BUDGET IMPACT ANALYSES: A REVIEW OF SUBMISSIONS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Feb 25, 2026, 14:43 PM -
REAL-WORLD HEALTHCARE RESOURCE UTILIZATION & ASSOCIATED DRIVERS AMONG PATIENTS WITH OSTEOGENESIS IMPERFECTA
Feb 25, 2026, 14:43 PM -
COST-EFFECTIVENESS OF PROCALCITONIN-GUIDED ANTIBIOTIC THERAPY IN ADULT PATIENTS WITH ACUTE RESPIRATORY INFECTION IN A COLOMBIAN REFERRAL HOSPITAL
Feb 25, 2026, 14:43 PM -
REAL WORLD HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH PANCREATIC CANCERIN THE BRAZILIAN PRIVATE MARKET
Feb 25, 2026, 14:43 PM -
END-OF-LIFE AGGRESSIVE CARE AND ITS INFLUENCING FACTORS AMONG LUNG CANCER PATIENTS IN CHINA: A REAL-WORLD STUDY BASED ON DATA FROM CITY A
Feb 25, 2026, 14:43 PM -
A HOLISTIC EVALUATION OF ADVERSE EFFECTS ASSOCIATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) IN PROSTATE CANCER: AN ARTIFICIAL INTELLIGENCE ASSISTED TARGETED LITERATURE REVIEW
Feb 25, 2026, 14:43 PM -
NOVEL PATIENT-CENTERED APPROACH TO CLINICAL TRIAL READINESS IN RARE DISEASES
Feb 25, 2026, 14:43 PM -
HEALTH-RELATED QUALITY OF LIFE AND HEALTH STATE UTILITY VALUES IN MODERATE TO VERY SEVERE COPD: A SYSTEMATIC LITERATURE REVIEW
Feb 25, 2026, 14:43 PM -
ANTI-ISH VACCINATION: PATTERNS OF CHILDHOOD VACCINE UPTAKE IN THE FIRST 24 MONTHS IN CHILDREN VACCINATED OR NOT FOR MEASLES/MUMPS/RUBELLA
Feb 25, 2026, 14:43 PM -
OUT-OF-POCKET COST BURDEN AMONG PATIENTS DIAGNOSED WITH BREAST CANCER AND MENTAL HEALTH COMORBIDITIES: A CROSS-SECTIONAL STUDY USING MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATA
Feb 25, 2026, 14:43 PM -
INTEGRATING SOCIAL INNOVATION INTO MEDICAL EDUCATION: AN EVALUATION PROTOCOL FOR AFYA’S CLOWN THERAPY PROJECT
Feb 25, 2026, 14:43 PM -
COMPARATIVE CARDIOVASCULAR AND KIDNEY EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS VERSUS OTHER GLUCOSE-LOWERING AGENTS IN PATIENTS WITH TYPE 2 DIABETES: A REAL-WORLD STUDY IN CHINA
Feb 25, 2026, 14:43 PM -
HEALTHCARE RESOURCE UTILIZATION AND TOTAL COST OF CARE FOR ELDERLY HF PATIENTS WHO ADD EMPAGLIFLOZIN TO TREATMENT REGIMEN
Feb 25, 2026, 14:43 PM -
CAN PUBMED ALONE CAPTURE THE EVIDENCE BASE FOR TARGETED LITERATURE REVIEWS? A CASE STUDY
Feb 25, 2026, 14:43 PM -
IMPACT OF ETEPLIRSEN TREATMENT INITIATION DELAYS ON LOSS OF AMBULATION INCIDENCE AMONG AMBULATORY PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY
Feb 25, 2026, 14:43 PM -
HEALTHCARE EXPENDITURE AMONG INDIVIDUALS LIVING WITH ALZHEIMER’S DISEASE: A JAPANESE PUBLIC HEALTHCARE PERSPECTIVE
Feb 25, 2026, 14:43 PM -
VALIDATION OF AN AGENTIC LARGE LANGUAGE MODEL (LLM) SYSTEM IN THE EXTRACTION STAGE OF A REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR): A SOLUTION TO INSTANT AND EASY ACCESS TO CLINICAL TRIAL DATA (CTD)
Feb 25, 2026, 14:43 PM
